Online Trial Tracker - Larvol Sigma

Genetic Diseases, Inborn

>>

>>

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Ph

N

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

KHK4577 / Kyowa Kirin

NCT02004119: Phase 2 Study of KHK4577

Completed

2

93

Japan

KHK4577, Placebo

Kyowa Kirin Co., Ltd.

Atopic Dermatitis

12/14

12/14

Download Options